These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9192821

  • 21. Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A:Cholesterol Acyltransferase (ACAT).
    Locke JA, Wasan KM, Nelson CC, Guns ES, Leon CG.
    Prostate; 2008 Jan 01; 68(1):20-33. PubMed ID: 18000807
    [Abstract] [Full Text] [Related]

  • 22. Identification and characterization of PLZF as a prostatic androgen-responsive gene.
    Jiang F, Wang Z.
    Prostate; 2004 Jun 01; 59(4):426-35. PubMed ID: 15065091
    [Abstract] [Full Text] [Related]

  • 23. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells.
    Church DR, Lee E, Thompson TA, Basu HS, Ripple MO, Ariazi EA, Wilding G.
    Prostate; 2005 May 01; 63(2):155-68. PubMed ID: 15486991
    [Abstract] [Full Text] [Related]

  • 24. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor.
    Zhu H, Mazor M, Kawano Y, Walker MM, Leung HY, Armstrong K, Waxman J, Kypta RM.
    Cancer Res; 2004 Nov 01; 64(21):7918-26. PubMed ID: 15520198
    [Abstract] [Full Text] [Related]

  • 25. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K, Uemura H, Ishiguro H, Kubota Y.
    Int J Mol Med; 2002 Aug 01; 10(2):173-6. PubMed ID: 12119554
    [Abstract] [Full Text] [Related]

  • 26. Proliferative response of human prostate cancer cell to hormone inhibited by androgen receptor antisense RNA.
    Jiang J, Wang LF, Fang YH, Jin FS, Jin WS.
    Chin Med J (Engl); 2004 May 01; 117(5):684-8. PubMed ID: 15161534
    [Abstract] [Full Text] [Related]

  • 27. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB, Nelson JB, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [Abstract] [Full Text] [Related]

  • 28. Gamma-glutamyl transpeptidase in glutathione biosynthesis.
    Zhang H, Forman HJ, Choi J.
    Methods Enzymol; 2005 Dec 01; 401():468-83. PubMed ID: 16399403
    [Abstract] [Full Text] [Related]

  • 29. Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.
    Butcher NJ, Tetlow NL, Cheung C, Broadhurst GM, Minchin RF.
    Cancer Res; 2007 Jan 01; 67(1):85-92. PubMed ID: 17210686
    [Abstract] [Full Text] [Related]

  • 30. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N, Korkmaz CG, Saatcioglu F.
    Oncogene; 2002 Feb 07; 21(7):1017-27. PubMed ID: 11850819
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D, Falany CN.
    Prostate; 2007 Sep 01; 67(12):1318-29. PubMed ID: 17626250
    [Abstract] [Full Text] [Related]

  • 32. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
    Kimura K, Markowski M, Bowen C, Gelmann EP.
    Cancer Res; 2001 Jul 15; 61(14):5611-8. PubMed ID: 11454715
    [Abstract] [Full Text] [Related]

  • 33. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 34. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 35. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.
    Gleave ME, Sato N, Sadar M, Yago V, Bruchovsky N, Sullivan L.
    J Cell Biochem; 1998 Jun 01; 69(3):271-81. PubMed ID: 9581866
    [Abstract] [Full Text] [Related]

  • 36. Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.
    Cronauer MV, Nessler-Menardi C, Klocker H, Maly K, Hobisch A, Bartsch G, Culig Z.
    Br J Cancer; 2000 Jan 01; 82(1):39-45. PubMed ID: 10638964
    [Abstract] [Full Text] [Related]

  • 37. The effect of acivicin, an inhibitor of gamma-glutamyl transpeptidase on mouse molar development in vitro.
    Piesco NP.
    J Biol Buccale; 1990 Dec 01; 18(4):313-9. PubMed ID: 1982767
    [Abstract] [Full Text] [Related]

  • 38. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.
    Kokontis J, Takakura K, Hay N, Liao S.
    Cancer Res; 1994 Mar 15; 54(6):1566-73. PubMed ID: 7511045
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
    Hanigan MH, Gallagher BC, Taylor PT, Large MK.
    Cancer Res; 1994 Nov 15; 54(22):5925-9. PubMed ID: 7954424
    [Abstract] [Full Text] [Related]

  • 40. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.
    Swinnen JV, Esquenet M, Heyns W, Rombauts W, Verhoeven G.
    Mol Cell Endocrinol; 1994 Sep 15; 104(2):153-62. PubMed ID: 7527352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.